Medicated Skin Care in China
Euromonitor International's Medicated Skin Care in China market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 50 | Publication date: Sep 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
MEDICATED SKIN CARE IN CHINA : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 5 Medicated Skin Care Company Shares by Value 2004-2008
Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
Table 7 Acne Treatments Brand Shares by Value 2005-2008
Table 8 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 9 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - CHINA
AMWAY (CHINA) CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Amway (China) Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 2 Amway (China) Co Ltd: Competitive Position 2008
BRISTOL-MYERS SQUIBB (SHANGHAI) TRADING CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 4 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 5 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Competitive Position 2008
GLAXOSMITHKLINE (TIANJIN) PHARM CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 6 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 7 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 8 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Competitive Position 2008
JIANGZHONG PHARMACEUTICAL CO - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Jiangzhong Pharmaceutical Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Jiangzhong Pharmaceutical Co Ltd: Competitive Position 2008
SANJIU ENTERPRISE GROUP - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Sanjiu Enterprise Group: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 Sanjiu Enterprise Group: Competitive Position 2008
TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Tianjin Tianshi Biological Development Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 14 Tianjin Tianshi Biological Development Co Ltd: Competitive Position 2008
TIBET LINZHI QIZHENG TIBETAN MEDICINE FTY - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Tibet Linzhi Qizheng Tibetan Medicine Fty: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 16 Tibet Linzhi Qizheng Tibetan Medicine Fty: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 17 Tibet Linzhi Qizheng Tibetan Medicine Fty: Competitive Position 2008
WYETH PHARMACEUTICAL CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 18 Wyeth Pharmaceutical Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 19 Wyeth Pharmaceutical Co Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 20 Wyeth Pharmaceutical Co Ltd: Competitive Position 2008
XIAN JANSSEN PHARMACEUTICAL LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 21 Xian Janssen Pharmaceutical Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 22 Xian Janssen Pharmaceutical Ltd: Competitive Position 2008
YUNNAN BAIYAO GROUP CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Yunnan Baiyao Group Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 24 Yunnan Baiyao Group Co Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 25 Yunnan Baiyao Group Co Ltd: Competitive Position 2008
OTC HEALTHCARE IN CHINA
EXECUTIVE SUMMARY
Growing health awareness and disposable incomes fuel growth
Vitamins and dietary supplements lead growth
Amway leads fragmented OTC healthcare
Chemists/pharmacies lead but direct selling grows fastest
Steady growth for forecast period
KEY TRENDS AND DEVELOPMENTS
Rising health-consciousness and self-medication
Convenience becomes increasingly important
Lifestyle changes shape growth
Players increasingly focus on specific consumer targets
Deep-rooted tradition impacts OTC healthcare
TERRITORY KEY TRENDS AND DEVELOPMENTS
East China
Mid China
North and Northeast China
Northwest China
South China
Southwest China
MARKET INDICATORS
Table 10 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 11 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 12 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 13 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 14 Sales of OTC Healthcare by Region: Value 2003-2008
Table 15 Sales of OTC Healthcare by Region: % Value Growth 2003-2008
Table 16 OTC Healthcare Company Shares by Value 2004-2008
Table 17 OTC Healthcare Brand Shares by Value 2005-2008
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 20 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 21 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Table 22 Forecast Sales of OTC Healthcare by Region: Value 2008-2013
Table 23 Forecast Sales of OTC Healthcare by Region: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 26 OTC Healthcare Switches 2005-2007
DEFINITIONS
Summary 27 Research Sources